BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales
***BioLargo's newly formed subsidiary, BioLargo CPG, will bring to consumers the authentic, independently safety-tested CupriDyne® technology under its own brand following the marketing success of the original Pooph products that generated more than $125 million in pet-care sales while under license from BioLargo.***
**WESTMINSTER, CA /** **ACCESS Newswire** **/ July 13, 2026 /** BioLargo, Inc. (OTCQX:BLGO) today announced that it is preparing to relaunch CupriDyne®-based consumer pet products under a yet-to-be-announced brand. Targeting pets first, the new consumer products subsidiary will eventually expand into household odor and cleaning products. Formed to fill the gap left by Pooph's ongoing withdrawal from the market, BioLargo will sell direct to consumers and through online marketplaces such as Amazon, leveraging a "digital-first" strategy that allows for hyper-specific audience targeting, real-time performance tracking, and flexible budgets, rather than depending on expensive television campaigns.
CupriDyne-based pet products generated over $125 million in sales while under license and marketed under the Pooph brand. Unfortunately, a series of business decisions by Pooph's management later culminated in its abandonment of CupriDyne-formulated products, the foreclosure of their assets by their lender, board and CEO resignations, and what appears to be the cessation of business operations. BioLargo always owned the CupriDyne technology and had to revoke Pooph's license. Now, the ownership of the Pooph brand is embroiled in litigation. "As a result, we have an opportunity to leverage the prior marketing success by introducing our own brand" said Joseph Provenzano, who will lead the new BioLargo consumer products subsidiary as CEO.
BioLargo's launch brings the CupriDyne® technology and BioLargo's original products back to consumers who loved them. According to Grand View Research1, the U.S. pet odor control and clean-up products market was valued at approximately $6.47 billion in 2023 and is projected to reach approximately $8.87 billion by 2030. BioLargo's initial launch into pet odor control is part of a much larger home and pet cleaning opportunity. The company views pet care as a proven, well-defined category where the difference between masking and eliminating odors is immediately obvious to consumers. **Unlike the Pooph brand, BioLargo's new brand will not be limited to pets, and will use the pet product launch to anchor a broader expansion of CupriDyne products across the home.**
BioLargo has assembled a team of branding, marketing, creative, and channel-sales experts with proven track records building and growing consumer brands nationally in the pet and household categories. It plans to release additional information, including the product line, the brand name, and key team members, as the product nears its formal launch.
"It will be great to get back into the pet odor control and consumer products business", said Dennis Calvert, BioLargo CEO. **"We have seen what can be done, and this time we will own the brand and control the marketing and distribution."**
**About BioLargo, Inc.**
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
**OP**
**Step by step to reevaluation:**
BioLargo just flipped the script on the CupriDyne story.
They’re relaunching CupriDyne‑based consumer pet products under their own brand, backed by the same odor‑control tech that helped build a national pet‑care hit with over $125M in sales at retail. BioLargo has always owned the IP and, after revoking Pooph’s license over non‑payment and contract breaches, is now stepping directly into a multi‑billion‑dollar pet odor and home‑cleaning market.
This time, instead of burning cash on massive TV ad campaigns, they’re talking about a digital‑first strategy: direct‑to‑consumer and Amazon‑focused, leveraging data, targeted creatives, and online performance marketing. Pets are just the beachhead – once the new brand is established, the stated plan is to expand CupriDyne applications across the home, so BioLargo finally keeps the brand equity and upside that its tech creates rather than handing most of it to a licensee.\[
**And remember:** the big 2025 revenue drop was largely driven by the Pooph licensing breakdown and its termination, which cratered reported sales and helped push the share price down.
Many investors used that weakness to extend their positions, effectively betting that owning the tech plus the brand will be worth more than collecting a minority royalty slice on someone else’s product.
So with BioLargo now relaunching CupriDyne‑based consumer products under its own brand, in a huge market, with a leaner digital strategy and full control of the IP and future brand equity… is the market still pricing this story off old Pooph headlines and past revenue, or is it starting to reevaluate what this could mean for BioLargo’s long‑term upside?